Skip to main content

Top New Hampshire Lawmaker Says Marijuana Could Be Legalized Despite Governor's Opposition

The marijuana policy debate is evolving so quickly now that more and more states keep joining the list of those that could legalize cannabis soon.

The latest development out of New Hampshire has already rendered incomplete the list of 2019 marijuana predictions I put together earlier this week.

Homegrown indoor pot plants and leavesGetty

Steve Shurtleff, the Democratic speaker of the state House of Representatives, now says that his chamber and the Senate likely have enough support to override a promised veto of marijuana legalization legislation from Gov. Chris Sununu ®.

“It’s going to pass,” the speaker told the Boston Globe for a story published on Friday. “It’s burying our head in the sand to think that if we continue to make it illegal in New Hampshire that people won’t be using marijuana.”

Earlier this month, Sununu said he would “absolutely” veto any marijuana legalization bill “regardless of what the language looks like.”

The optimism about ending cannabis prohibition is a new position for Shurtleff, who himself opposed adding a pro-legalization plank in the state Democratic Party’s platform this summer.

“If the vote was today, I would probably be voting ‘no’ simply because there is a legislative commission that’s meeting to look at the impact of legalization on the state of New Hampshire,” he said at the time. “As a courtesy to those serving on the commission, I would wait until they finish their work and issue their report.”

That study commission’s report, released in November, found that legalizing marijuana would generate up to $58 million in annual tax revenue.

Earlier this year, the New Hampshire House approved legislation to legalize possession of small amounts of marijuana as well as limited home cultivation but later moved the bill back to a committee, where members recommended conducting the study instead of advancing the legislation to the Senate.

Shurtleff, the newly seated speaker, who is also a retired U.S. marshal, voted against that marijuana legalization bill and an earlier one that passed the House in 2014.

“Rep. Shurtleff’s evolution on cannabis reflects an encouraging trend among elected Democrats in New Hampshire,” Matt Simon, New England political director for the Marijuana Policy Project, said in an interview. “While Gov. Sununu and many Republicans have inexplicably doubled down on their support for prohibition, Shurtleff and most Democrats can see that regulating cannabis is both good politics and smart policy.”

Sununu, who was reelected in November’s midterms, signed a bill decriminalizing cannabis possession last year.

But although he has opposed going further by completely legalizing marijuana, his opposition may not matter if Shurtleff is correct that enough lawmakers support the move and would vote to override the governor.

This week, Rep. Renny Cushing (D), who has been a leader on cannabis reform in New Hampshire for several years, released details of a legalization bill he plans to file soon in the new session. Unlike the legislation that passed the House this year, the new proposal would create a system of legal and regulated cannabis sales in addition to allowing adults to grow their own.

“We’ve done our best to address every concern that was raised” by the legislature’s marijuana study committee, Cushing said.

The effort to pass his bill or something like it will likely get an additional boost from the fact that Democrats took control of both chambers of the legislature in last month’s midterm elections. As part of that sweep, several anti-legalization Republican incumbents were defeated and replaced with Democratic supporters.

For now, according New Hampshire’s House speaker, the list of states that could legalize marijuana in 2019 just got longer by one.

Original Article Source: https://www.forbes.com/sites/tomangell/2018/12/28/top-new-hampshire-lawmaker-says-marijuana-could-be-legalized-despite-governors-opposition/

Comments

Popular posts from this blog

Could CBD Lead To The Development Of Safer Antipsychotic Medications?

Antipsychotic medications are important for managing a number of different psychiatric ailments, including bipolar disorders, schizophrenia, and even dementia. These drugs can greatly improve the manageability of symptoms that often distort one’s experience of reality. They can also create major mood disruptions and lead to a number of behavioral and emotional difficulties. Antipsychotic and anti-psychosis medications can be life-changing for people with such disorders, enabling them to live more normal and manageable lives without their symptoms taking over. These drugs work by regulating neurotransmitters in the brain so that naturally occurring imbalances and dysfunctions no longer disrupt mental and emotional processes. Often, reaching this outcome is much easier said than done; it can take a lot of time to find courses and combinations of treatments that work. It’s sometimes necessary to make adjustments to find the right balance for the individual and it’s not unusual for outc...

Can Medical Marijuana Help Aging Parents With Dementia?

For decades, marijuana, even for medical uses, was demonized or questioned.  When states like Colorado legalized it for recreational use, more studies began to determine provable efficacy for its use as a medicine. The Federal government still classifies marijuana the same way it classifies heroin: harmful and with no medical benefits. Now we can see that this is wrong. When states legalized marijuana, referred to as cannabis here, they had an interest in getting data to see what good it could do. Proving efficacy could increase medical marijuana sales, benefit people who might at least find some medical use, and overall would bring tax dollars into the state coffers. Without funding studies, the Federal government has done very little to demonstrate what good cannabis can do. After all, if the presumption is that it helps nothing, there would be no motivation to determine with scientific data that it does anyone any good. But we have convincing data now about its beneficial use ...

Cannabis Watch: Canopy Growth To Book Charge Of Up To $568 Million As Marijuana Restructuring Continues

Canopy Growth Corp. said early Thursday it was halting a range of operations across three continents and expects its restructuring plans to result in a charge of up to C$800 million (567.9 million) in the fiscal fourth quarter. U.S.-traded shares US:CGC CA:WEED of the cannabis company fell 1.9% in afternoon trading. Canopy said it was selling operations in Africa, curtailing cultivation of hemp in the U.S. and Columbia, and shutting down an indoor production facility in Canada. The announcement will result in 85 job cuts, the company said. “When I arrived at Canopy Growth in January, I committed to conducting a strategic review in order to lower our cost structure and reduce our cash burn,” Canopy Chief Executive David Klein said in a statement. Read: As cannabis industry stays largely quiet on coronavirus, this CEO has been sounding the alarm Canopy’s restructuring announcement was expected by investors, Cowen analyst Vivien Azer wrote in a note to clients Thursday. Azer rate...